QIMR Berghofer maintains an extensive intellectual property portfolio, including technologies in oncology and infectious disease areas. We seek commercial partners who have an interest in the research and development of seed and early-stage technologies that have the potential to grow rapidly into successful businesses.
QIMR Berghofer currently holds patents in the following areas:
- Cancer diagnostics.
- Cancer therapeutic targets.
- Cancer vaccines.
- Drug delivery platforms.
- Infectious disease vaccines.
- Therapeutic antibodies.
- Vaccine delivery platforms.
QIMR Berghofer has a number of potential licensing opportunities available, including cancer therapeutic and diagnostic targets, cancer vaccines and infectious disease vaccines.
Please contact the Business Development Office for more details.